Differential prevalence of transporter polymorphisms in symptomatic and asymptomatic falciparum malaria infections in Uganda

Journal of Infectious Diseases

Volumn 210, Issue 1, 2014, Pages 154-157

  Tukwasibwe, Stephen ^a   Mugenyi, Levi ^a   Mbogo, George W ^a   Nankoberanyi, Sheila ^a   Maiteki Sebuguzi, Catherine ^a   Joloba, Moses L ^b   Nsobya, Samuel L ^a   Staedke, Sarah G ^c   Rosenthal, Philip J ^d  

^a INFECTIOUS DISEASES RESEARCH COLLABORATION   (Uganda)

^b MAKERERE UNIVERSITY   (Uganda)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Fitness; Malaria; Plasmodium; Polymorphism; Virulence

Indexed keywords

ADOLESCENT; AGE; ARTICLE; ASYMPTOMATIC INFECTION; CASE CONTROL STUDY; CHILD; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEVER; GENE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; NONHUMAN; PARASITE PREVALENCE; PARASITE VIRULENCE; PFCRT GENE; PFMDR1 GENE; PLASMODIUM FALCIPARUM; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RURAL AREA; UGANDA;

ADOLESCENT; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; DRUG RESISTANCE; FEMALE; HUMANS; INFANT; MALARIA, FALCIPARUM; MALE; MEMBRANE TRANSPORT PROTEINS; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; PLASMODIUM FALCIPARUM; POLYMORPHISM, GENETIC; PROTOZOAN PROTEINS; RETROSPECTIVE STUDIES; UGANDA; VIRULENCE;

EID: 84904316256     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiu044     Document Type: Article

References (15)

1. Rosenthal PJ. The interplay between drug resistance and fitness in malaria parasites. Mol Microbiol 2013; 89:1025-38.
2. Ecker A, Lehane AM, Clain J, Fidock DA. PfCRT and its role in antimalarial drug resistance. Trends Parasitol 2012; 28:504-14.
3. Laufer MK, Thesing PC, Eddington ND, et al. Return of chloroquine antimalarial efficacy in Malawi. N Engl J Med 2006; 355:1959-66.
4. Hayward R, Saliba KJ, Kirk K. pfmdr1 mutations associated with chloroquine resistance incur a fitness cost in Plasmodium falciparum. Mol Microbiol 2005; 55:1285-95.
5. Ochong E, Tumwebaze PK, Byaruhanga O, Greenhouse B, Rosenthal PJ. Fitness consequences of Plasmodium falciparum pfmdr1 polymorphisms inferred from ex vivo culture of Ugandan parasites. Antimicrob Agents Chemother 2013; 57:4245-51.
6. Ord R, Alexander N, Dunyo S, et al. Seasonal carriage of pfcrt and pfmdr1 alleles in Gambian Plasmodium falciparum imply reduced fitness of chloroquine-resistant parasites. J Infect Dis 2007; 196:1613-9.
7. Ranjit MR, Das A, Chhotray GP, Das BP, Das BN, Acharya AS. The PfCRT (K76T) point mutation favours clone multiplicity and disease severity in Plasmodium falciparum infection. Trop Med Int Health 2004; 9:857-61.
8. Wele M, Djimde AA, Guindo A, et al. High frequency of PfCRT 76T in two Malian villages and its prevalence in severe relative to non-severe malaria. Acta Trop 2011; 119:11-3.
9. Giha HA, Elbashir MI, IE AE, et al. Drug resistance-virulence relationship in Plasmodium falciparum causing severe malaria in an area of seasonal and unstable transmission. Acta Trop 2006; 97:181-7.
10. Mayengue PI, Kalmbach Y, Issifou S, Kremsner PG, Ntoumi F. No variation in the prevalence of point mutations in the Pfcrt and Pfmdr1 genes in isolates from Gabonese patients with uncomplicated or severe Plasmodium falciparum malaria. Parasitol Res 2007; 100:487-93.
11. Staedke SG, Chandler CI, Diliberto D, et al. The PRIME trial protocol: evaluating the impact of an intervention implemented in public health centres on management of malaria and health outcomes of children using a cluster-randomised design in Tororo, Uganda. Implement Sci 2013; 8:114.
12. Nsobya SL, Kiggundu M, Nanyunja S, Joloba M, Greenhouse B, Rosenthal PJ. In vitro sensitivities of Plasmodium falciparum to different antimalarial drugs in Uganda. Antimicrob Agents Chemother 2010; 54: 1200-6.
13. Nsobya SL, Kiggundu M, Joloba M, Dorsey G, Rosenthal PJ. Complexity of Plasmodium falciparum clinical samples from Uganda during shortterm culture. J Infect Dis 2008; 198:1554-7.
14. Ogouyemi-Hounto A, Ndam NT, Kinde Gazard D, et al. Prevalence of the molecular marker of Plasmodium falciparum resistance to chloroquine and sulphadoxine/pyrimethamine in Benin seven years after the change of malaria treatment policy. Malar J 2013; 12:147.
15. Baliraine FN, Rosenthal PJ. Prolonged selection of pfmdr1 polymorphisms after treatment of falciparum malaria with artemether-lumefantrine in Uganda. J Infect Dis 2011; 204:1120-4.